PC
PRNB

Polar Capital’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Polar Capital’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-130,524
Closed -$7.8M – 333
2020
Q2 		$7.8M Sell
130,524
-302,322
-70% -$18.7M 0.07% 188
2020
Q1 		$25.7M Buy
+432,846
New +$25.2M 0.28% 106
2019
Q2 		– Sell
-75,000
Closed -$2.55M – 310
2019
Q1 		$2.55M Sell
75,000
-25,000
-25% -$795K 0.02% 238
2018
Q4 		$2.74M Hold
100,000
– – 0.03% 228
2018
Q3 		$2.92M Buy
+100,000
New +$2.82M 0.02% 237

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Polar Capital's PRNB Position: Q3 2020 in Review

Polar Capital sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 130,524 shares — an estimated $7.8M sold.

Polar Capital first reported a position in PRNB in Q3 2018 and held it in 5 quarters. The position peaked at $25.7M in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Polar Capital reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Polar Capital sold 130,524 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $7.8M.
  • Polar Capital first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 5 quarters.
  • Polar Capital's Principia Biopharma Inc. Common Stock position peaked at $25.7M in Q1 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.